NewsBeat
AstraZeneca ditches lung cancer treatment trial
But the Anglo-Swedish group, which is headquartered in Cambridge, also revealed some oncology drug success on Monday with the announcement that its Enhertu treatment showed “a statistically significant and clinically meaningful improvement in progression-free survival” for non-small cell lung cancer patients.
You must be logged in to post a comment Login